Oncology Today with Dr Neil Love

Episode Archive

Episode Archive

84 episodes of Oncology Today with Dr Neil Love since the first episode, which aired on April 9th, 2020.

  • PARP Inhibitors in Breast Cancer Edition

    September 23rd, 2020  |  58 mins 53 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a discussion on recent advances in the use of PARP inhibitors in breast cancer with Dr Susan Domchek, moderated by Neil Love, MD.

  • Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition

    September 21st, 2020  |  41 mins 38 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a discussion on recent advances in the treatment of myeloproliferative neoplasms with Dr Srdan Verstovsek, moderated by Neil Love, MD.

  • Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition

    September 17th, 2020  |  51 mins 47 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, mutations, oncology, oncology education, research to practice, telemedicine

    Featuring a discussion on recent advances in the treatment of EGFR mutation-positive non-small cell lung cancer with Dr Pasi Jänne, moderated by Neil Love, MD.

  • Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition

    September 15th, 2020  |  42 mins 53 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, multiple myeloma, oncology, oncology education, research to practice

    For this special edition of Oncology Today, I met with Dr Nikhil Munshi from the Dana-Farber Cancer Institute in Boston to discuss recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma.

  • Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition

    September 11th, 2020  |  46 mins 35 secs
    bladder cancer, cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a discussion on recent advances in the use of immunotherapy for urothelial bladder cancer with Dr Petros Grivas, moderated by Neil Love, MD.

  • Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition

    September 4th, 2020  |  39 mins 39 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice, skin cancer

    For this special edition of Oncology Today, I met with Dr Nikhil Khushalani from Moffitt Cancer Center to discuss recent data and optimal management of cutaneous squamous cell carcinoma.

  • Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition

    August 28th, 2020  |  45 mins 25 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer.

  • Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard

    August 18th, 2020  |  1 hr 26 mins
    cancer, cancer treatment, chemotherapy, dr neil love, follicular lymphoma, immunotherapy, oncology, oncology education, research to practice

    Featuring a roundtable discussion on recent data and optimal management of follicular lymphoma with Drs Carla Casulo and John P Leonard moderated by Neil Love, MD.

  • Oncology Today Special Roundtable: Colorectal Cancer

    August 5th, 2020  |  1 hr 30 mins
    cancer, cancer treatment, chemotherapy, colorectal cancer, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD.

  • Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson

    August 1st, 2020  |  15 mins 34 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.

  • Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer

    June 16th, 2020  |  15 mins 13 secs
    cancer, cancer treatment, chemotherapy, dr neil love, oncology, oncology education, pancreatic cancer, research to practice

    Is it worthwhile to treat pancreatic cancer? Dr Michael Pishvaian from Johns Hopkins University discusses the use of the PARP inhibitor olaparib and other new developments in the disease.

  • Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2

    June 5th, 2020  |  27 mins 40 secs
    cancer, cancer treatment, chemotherapy, chronic lymphocytic leukemia, cll, covid, covid-19, dr neil love, hematology, oncology, oncology education, research to practice, sars-cov2

    Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2.

  • Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19

    May 27th, 2020  |  16 mins 4 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, nurses, nursing, oncology, oncology education, oncology nurse, research to practice, telemedicine

    Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care.

  • Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era

    May 19th, 2020  |  19 mins 32 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.

  • Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic

    May 15th, 2020  |  14 mins 26 secs
    brca, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, gynecologic cancer, immunotherapy, metastatic, oncology, oncology education, ovarian cancer, parp, research to practice, telemedicine

    Dr Kathleen Moore from the Stephenson Cancer Center and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer.

  • Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic

    May 3rd, 2020  |  25 mins 13 secs
    brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine

    Dr Julie Gralow reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19.